Skip to content

Manual Therapy plus advice to stay active in patients with chronic leg pain

Neural management plus advice to stay active in patients with chronic sciatica

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3db643c
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica

Interventions

The experimental group will receive advice to stay active associated with neural management, and the control group will receive advice to stay active alone. We will recruit 105 participants per group,
E02.190.599
I02.233.332

Sponsors

Centro Universitário Augusto Motta
Lead Sponsor
Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults with chronic sciatica; moderate or severe leg pain intensity; 18-65 years old; both sexes

Exclusion criteria

Exclusion criteria: Participants in treatment due to sciatica; participants planning to undergo any other procedures for sciatica treatment in the study period; present known or signs of serious spinal pathology; history of abdominal, lumbar, or lower limb surgery in the past year; rheumatologic disease in the acute inflammatory phase; if they are receiving disability compensation due to LBP; pregnant or puerperal women; self-reported psychiatric diagnosis; history of cancer; and cancer-related pain

Design outcomes

Primary

MeasureTime frame
We will evaluate leg pain intensity and functional limitation of patients with chronic sciatica. It is expected that patients with chronic sciatica allocated to the neural management group added advice to remain active will have a statistically significant reduction in pain intensity and improved functionality after the treatment period (short, medium and long term) in a way superior to patients with chronic sciatica allocated in the group of only advice to remain active

Secondary

MeasureTime frame
We will evaluate neuropathic symptoms, sciatic neurodynamic, pain modulation, and psychosocial factors. It is expected that patients included in the experimental group will improve the sciatic neurodynamic after the treatment period in a superior way compared to the control group. The analysis of the participant's baseline characteristics will provide information on the most relevant aspects of the participant's self-reported pain perception. In addition, the analysis of mediators will make it possible to identify potential factors that explain the clinical improvement of the participant with chronic sciatica submitted to the study interventions.

Countries

Brazil

Contacts

Public ContactJuliana ;Leticia Bittencourt;Corrêa

;

julianavalentim@souunisuam.com.br;leticiaamaral@souunisuam.com.br+55-24-988150866;+55-21-979100168

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 13, 2026